Actinium Pharmaceuticals Inc. buy BiotechBee
Start price
04.02.24
/
60%
€4.84
Target price
31.10.25
€7.00
Performance (%)
-66.38%
End price
19.08.24
€1.63
Summary
This prediction ended on 19.08.24 with a price of €1.63. The BUY prediction by BiotechBee for Actinium Pharmaceuticals Inc. performed very badly with a performance of -66.38%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Actinium Pharmaceuticals Inc. | 14.078% | 14.078% | 20.719% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
According to BiotechBee what are the pros and cons of Actinium Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Actinium Pharmaceuticals Inc. diskutieren
In the thread Trading Actinium Pharmaceuticals Inc.
Stopped prediction by BiotechBee for Actinium Pharmaceuticals Inc.
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.30
10.12.23
10.12.23
€6.00
31.05.25
31.05.25
-8.68%
04.02.24
04.02.24
Could be very worthwhile Investment >20% year
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.30
06.02.23
06.02.23
€20.00
31.12.25
31.12.25
-29.20%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.47
31.10.22
31.10.22
€18.00
31.12.24
31.12.24
19.77%
31.10.22
31.10.22
Could be very worthwhile Investment >20% year